Skip to main content
. Author manuscript; available in PMC: 2009 Jun 15.
Published in final edited form as: Bioorg Med Chem. 2008 May 9;16(12):6338–6343. doi: 10.1016/j.bmc.2008.05.015

Figure 3.

Figure 3

Competitive binding experiments that monitor the retention of fluorescein-labeled GU40C4 by immobilized VEGFR2 ECD in the presence of the indicated concentrations of unlabeled competitor (VEGF, unlabeled GU40C4 or a control peptoid not selected to bind VEGFR2). Only unlabeled GU40C4 competed the GU40C4-FITC•VEGFR2 ECD complex.